A combination of molecular and clinical parameters provides a new strategy for high-grade serous ovarian cancer patient management

BACKGROUND: High-grade serous carcinoma (HGSC) is the most common and deadly subtype of ovarian cancer. Although most patients will initially respond to first-line treatment with a combination of surgery and platinum-based chemotherapy, up to a quarter will be resistant to treatment. We aimed to ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Bradbury, Melissa, Borràs, Eva, Vilar, Marta, Castellví, Josep, Sánchez-Iglesias, José Luis, Pérez-Benavente, Assumpció, Gil-Moreno, Antonio, Santamaria, Anna, Sabidó, Eduard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773449/
https://www.ncbi.nlm.nih.gov/pubmed/36544142
http://dx.doi.org/10.1186/s12967-022-03816-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773449/
https://www.ncbi.nlm.nih.gov/pubmed/36544142
http://dx.doi.org/10.1186/s12967-022-03816-7

Ejemplares similares